“Toxicity studies were conducted in a single species, i.e. cynomolgus monkeys, based on comparable binding affinity and functional activity of teprotumumab to human and cynomolgus IGF-1R and lack of reactivity with rodent IGF-1R.”
Comparable binding affinity and functional activity at human and cynomolgus IGF-1R; no reactivity with rodent IGF-1R
“Toxicity studies were conducted in a single species, i.e. cynomolgus monkeys, based on comparable binding affinity and functional activity of teprotumumab to human and cynomolgus IGF-1R and lack of reactivity with rodent IGF-1R.”
No surrogate; the clinical antibody was tested in cynomolgus monkeys
“Toxicity studies were conducted in a single species, i.e. cynomolgus monkeys, based on comparable binding affinity and functional activity of teprotumumab to human and cynomolgus IGF-1R and lack of reactivity with rodent IGF-1R.”